MYC and lung cancer: 5‐Hydroxytryptamine may enhance tumorigenicity and increase the risk of distant metastasis in non‐small cell lung cancer patients through 5‐HT‐c‐Myc‐SLC6A4 axis, suggesting that SLC6A4 was an important molecule in tumorigenesis and metastasis.28